X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2021/07/01/2256444/28235/en/Rafael-Pharmaceuticals-Announces-Positive-Preplanned-Interim-Futility-Analysis-of-Pivotal-Phase-3-Trial-ARMADA-2000-of-CPI-613-Devimistat-for-Relapsed-or-Refractory-Acute-Myeloid-L.html